检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王鹏 王毅东 赵文兵 WANG Peng;WANG Yidong;ZHAO Wenbin(Shanxi Hospital of Integrated Traditional and Western Medicine, Taiyuan,Shanxi 030013)
机构地区:[1]山西省中西医结合医院泌尿外科,山西太原030013
出 处:《中国中医药科技》2019年第3期339-343,共5页Chinese Journal of Traditional Medical Science and Technology
基 金:山西省科技攻关项目(20150313005-12)
摘 要:目的:探讨扶正利湿抗癌方含药血清对前列腺癌细胞株PC-3体外增殖能力的影响及其作用机制。方法:应用CCK-8法测定不同浓度扶正利湿抗癌方含药血清对PC-3细胞生长抑制情况,流式细胞仪检测其对PC-3细胞凋亡及细胞周期的影响,并以Western blot分析扶正利湿抗癌方含药血清对PC-3细胞凋亡调控蛋白bcl-2和bax蛋白表达的影响。结果:扶正利湿抗癌方含药血清对PC-3细胞体外增殖抑制作用明显,呈浓度及时间依赖性。流式结果显示,扶正利湿抗癌方含药血清可诱导PC-3细胞凋亡,并能够增加G_2/M期细胞比例,降低S期细胞比例,呈浓度依赖性。Western blot结果显示,扶正利湿抗癌方含药血清可下调bcl-2蛋白的表达,而上调bax蛋白的表达,呈浓度依赖性。结论:扶正利湿抗癌方含药血清可以通过调节bcl-2和bax蛋白的表达发挥体外抑制PC-3细胞增殖的作用。Objective: To explore the effects of Fuzheng Lishi Tang on the proliferatio of prostate cancer PC-3 cell lines and exploring the mechanism. Methods: The inhibitory effects of Fuzheng Lishi Tang on growth of PC-3 cells were detected by using CCK-8 assay. The influence of Fuzheng Lishi Tang on apoptosis and cell cycle of PC-3 cells was detected by flow cytometer. The influence of Fuzheng Lishi Tang on protein expressions of bcl-2 and bax of PC-3 cells was analyzed by Western blotting method. Results: The Fuzheng Lishi Tang had inhibitory effect on proliferation of PC-3 cells, its effective time and dose were positively correlated to cellular proliferation inhibition rate. The FCM results demonstrated that the Fuzheng Lishi Tang blocked the cell cycle in the G 2/M phase.Western blot results showed that the Fuzheng Lishi Tang could down-regulate protein expressions of bcl-2 and up-regulate the expression bax of PC-3 cells. Conclusion: The Serum Containing Fuzheng Lishi Tang can inhibit the proliferation of PC-3 cells in vitro by regulating the expression of Bcl-2 and Bax proteins.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145